Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Kaufman & Broad SA: HALF-YEAR  LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA
Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA
Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA
DGAP-News: Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference
DGAP-News: Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference
DGAP-News: Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference
DGAP-News: Abivax präsentiert auf der J.P. Morgan 40th Annual Healthcare Conference
DGAP-News: Abivax präsentiert auf der J.P. Morgan 40th Annual Healthcare Conference
DGAP-News: Abivax präsentiert auf der J.P. Morgan 40th Annual Healthcare Conference
DGAP-News: Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitis
DGAP-News: Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitis
DGAP-News: Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitis
DGAP-News: Abivax erhält Feedback der US-Amerikanischen Zulassungsbehörde mit Guidance zur Überführung von ABX464 in die klinische Phase-3-Testung
DGAP-News: Abivax erhält Feedback der US-Amerikanischen Zulassungsbehörde mit Guidance zur Überführung von ABX464 in die klinische Phase-3-Testung
DGAP-News: Abivax erhält Feedback der US-Amerikanischen Zulassungsbehörde mit Guidance zur Überführung von ABX464 in die klinische Phase-3-Testung
DGAP-News: Abivax's phase 1/2 clinical study results of ABX196 in liver cancer show good tolerability and promising signals of clinical benefit and were selected for presentation at the ASCO GI Cancers Symposium
DGAP-News: Abivax's phase 1/2 clinical study results of ABX196 in liver cancer show good tolerability and promising signals of clinical benefit and were selected for presentation at the ASCO GI Cancers Symposium
DGAP-News: Abivax's phase 1/2 clinical study results of ABX196 in liver cancer show good tolerability and promising signals of clinical benefit and were selected for presentation at the ASCO GI Cancers Symposium
DGAP-News: Abivax' Phase-1/2-Studienergebnisse mit ABX196 zur Behandlung von Leberkrebs zeigen gute Sicherheit und vielversprechende Anzeichen klinischen Nutzens ...
DGAP-News: Abivax' Phase-1/2-Studienergebnisse mit ABX196 zur Behandlung von Leberkrebs zeigen gute Sicherheit und vielversprechende Anzeichen klinischen Nutzens ...
DGAP-News: Abivax' Phase-1/2-Studienergebnisse mit ABX196 zur Behandlung von Leberkrebs zeigen gute Sicherheit und vielversprechende Anzeichen klinischen Nutzens ...
Freelance.com: Organic growth in Q3 2021: +32%. Positive trend across all the Group's activities
Freelance.com: Organic growth in Q3 2021: +32%. Positive trend across all the Group's activities
Freelance.com: Organic growth in Q3 2021: +32%. Positive trend across all the Group's activities
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value: https://www.marketbeat.com/logos/articles/med_20240925091256_bausch-health-a-buyout-bid-could-be-the-ticket-to.jpg
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

Bausch Health (NYSE: BHC) stock has been on a wild ride recently, with a dramatic surge in value over the last month. The catalyst for this surge is a wave of rumors suggesting that Bausch +

Williams Sonoma Stock Could Be Ripe for a Short at Current Levels: https://www.marketbeat.com/logos/articles/med_20240923134358_williams-sonoma-stock-could-be-ripe-for-a-short-at.jpg
Williams Sonoma Stock Could Be Ripe for a Short at Current Levels

Investors can save a lot of money and even boost their potential returns when they realize that there is one major difference between a stock and a business. Apple Inc. (NASDAQ: AAPL) might be an

2 Avocado Stocks Proving the Superfood Can Be a Super Investment: https://www.marketbeat.com/logos/articles/med_20240917142044_2-avocado-stocks-proving-the-superfood-can-be-a-su.jpg
2 Avocado Stocks Proving the Superfood Can Be a Super Investment

Rich in antioxidants like Omega 3, magnesium, potassium, fiber, and lutein, as well as nutrients, including vitamins A through E and K, the avocado is a superfood (and a fruit). Last year, the

Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge: https://www.marketbeat.com/logos/articles/med_20240917091551_gold-hits-new-all-time-highs-3-stocks-to-ride-the.jpg
Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge

Gold has surged to a new all-time high, rising 33.5% over the past year to $2,583.64/oz. This is driven by easing inflation and expectations that the Federal Reserve will cut interest rates after

What Buybacks and Lower Rates Could Mean for Restaurant Brands: https://www.marketbeat.com/logos/articles/med_20240917083614_what-buybacks-and-lower-rates-could-mean-for-resta.jpg
What Buybacks and Lower Rates Could Mean for Restaurant Brands

Restaurant Brands (NYSE: QSR) owns massive fast-food chains like Burger King, Popeyes, and Tim Hortons. The company has received approval for its share buyback program, under which it will be able

Silver’s Breakout: 3 Momentum Stocks You Can’t Miss: https://www.marketbeat.com/logos/articles/med_20240916141404_3-momentum-stocks-to-watch-as-silver-prices-break.jpg
Silver’s Breakout: 3 Momentum Stocks You Can’t Miss

The global financial cycle has a few tail ends, and the two are typically divided between stocks and commodities. When one performs, the other tends to underperform, with currency performance in

Why Zillow Group Could Soar with the Upcoming Interest Rate Cuts: https://www.marketbeat.com/logos/articles/med_20240915183935_chatt-zg.jpg
Why Zillow Group Could Soar with the Upcoming Interest Rate Cuts

Real estate brokers and online real estate marketplace stocks are surging in anticipation of the Federal Reserve interest rate cut cycle commencing, and investors are paying attention.

Among the

RH’s Transformation Pay Off Will Accelerate with Rate Cuts: https://www.marketbeat.com/logos/articles/med_20240915184853_chartw-rh.jpg
RH’s Transformation Pay Off Will Accelerate with Rate Cuts

Formerly known as Restoration Hardware, RH (NYSE: RH) is a high-end home furnishings retailer offering curated collections of luxury furniture, decor, bathware and textiles. Its stock surged 25%

3 Defensive Stock Alternatives to Bonds If Interest Rates Drop: https://www.marketbeat.com/logos/articles/med_20240913133242_3-defensive-stock-alternatives-to-bonds-if-interes.jpg
3 Defensive Stock Alternatives to Bonds If Interest Rates Drop

Bonds play a central role in the investment strategies of many defensive or conservative investors. The price of bonds shifts in an inverse fashion compared to yields, meaning that as the Federal

Can Celsius Stock Rebound? Analysts See 74% Upside Potential: https://www.marketbeat.com/logos/articles/med_20240913111124_can-celsius-stock-rebound-analysts-see-74-upside-p.jpg
Can Celsius Stock Rebound? Analysts See 74% Upside Potential

Celsius Holdings, Inc. (NASDAQ: CELH) is the maker of the popular Celsius energy drink, formulated to power active lifestyles with its unique blend of essential vitamins. Celsius’s line of

3 Stocks That Could See Rising Demand Based on Latest Jobs Data: https://www.marketbeat.com/logos/articles/med_20240912084137_3-stocks-that-could-see-rising-demand-based-on-lat.jpg
3 Stocks That Could See Rising Demand Based on Latest Jobs Data

Looking into jobs data isn’t just useful for understanding how strong the general economy is. It can also provide insight into what types of companies might be preparing for increases in the

3 Key Reasons Why Rocket Companies Stock Will Rally Soon: https://www.marketbeat.com/logos/articles/med_20240911111854_3-key-reasons-why-rocket-companies-stock-will-rall.jpg
3 Key Reasons Why Rocket Companies Stock Will Rally Soon

Markets will always have a reason to keep the market going, and always come up with reasons as to why a stock might be falling, whether these reasons are valid or not. Today, investors need to cut

Verint Systems' AI Bots Revolutionize Customer Service Efficiency: https://www.marketbeat.com/logos/articles/med_20240908180437_chartw-vrnt.jpg
Verint Systems' AI Bots Revolutionize Customer Service Efficiency

When you call a customer service line and are greeted with an automated voice system that attempts to confirm your identity and inquire about your issue, you may be engaging with an artificial

Is Redfin Stock a Buy? Housing Market Recovery Could Fuel Upside: https://www.marketbeat.com/logos/articles/med_20240908180736_chartw-rdfn.jpg
Is Redfin Stock a Buy? Housing Market Recovery Could Fuel Upside

Residential real estate brokerage Redfin Co. (NASDAQ: RDFN) has been a disrupter in the finance sector, specifically in the residential real estate industry. The company has been losing money in

Amazon Stock is a Red Hot Bargain (For Now): https://www.marketbeat.com/logos/articles/med_20240910081246_amazon-stock-is-a-red-hot-bargain-for-now.jpg
Amazon Stock is a Red Hot Bargain (For Now)

Since hitting an all-time high in July, shares of Amazon.com Inc (NASDAQ: AMZN) have been struggling to find their feet. It had seemed at the time that the solid first half they’d had to the year

3 Financial Stocks to Watch as Interest Rate Cuts Approach: https://www.marketbeat.com/logos/articles/med_20240909160007_3-financial-stocks-to-watch-as-interest-rate-cuts.jpg
3 Financial Stocks to Watch as Interest Rate Cuts Approach

The stock market has now priced in the interest rate cut narrative. Investors can point to this idea by watching how the S&P 500 has gone from an uptrend market to a channeling—or even

Seize the Opportunity: Under Armour Stock Set for a Comeback: https://www.marketbeat.com/logos/articles/med_20240908182106_chartw-uaa.jpg
Seize the Opportunity: Under Armour Stock Set for a Comeback

Global athletic apparel and footwear brand Under Armour Inc. (NYSE: UAA) is steadily gaining ground on its turnaround plan. The company had a setback when former CEO Stephanie Linnartz abruptly